Stock listing

Cboe Canada:QPT Quest PharmaTech Inc. Stock

Canadian listing (Cboe Canada) of Quest PharmaTech Inc. · home listing TSXV:QPT

Follow Quest PharmaTech Inc. into a list and get an email when it puts out news.

Home listing price · TSXV:QPT

$0.02 CAD 0.00 (0.0%)

Close on Nov 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:QPT

Past year -50.0% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.02 – $0.02 CADNov 19, 2026
Market cap
$3.38M CADAt the close on Nov 19, 2026 · price × 169.1M shares outstanding
52-week range
$0.02 – $0.05 CADLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$170 CADMedian day 0 shares · 50 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
Quest PharmaTech Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSXV:QPT · Home$0.02 CAD0.00 (0.0%)—$0.02$0.02$0.02$0.02Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · TSXV:QPT · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.021,250
$0.020.000.0%$0.02$0.02$0.0267,000
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.0290,000
$0.020.000.0%$0.02$0.02$0.029,100
$0.020.000.0%$0.02$0.02$0.020
$0.02-0.01-33.3%$0.02$0.02$0.028,100
$0.030.000.0%$0.03$0.03$0.035,600
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.03+0.01+50.0%$0.03$0.03$0.0325,500
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.022,000
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.02120,000
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.021,500
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.02-0.01-33.3%$0.02$0.02$0.024,000
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.0316,000
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.03+0.01+50.0%$0.03$0.03$0.03105,200
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.0210,000
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.020
$0.020.000.0%$0.02$0.02$0.0210,000
Ticker
Cboe Canada:QPT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Cboe Canada
Currency
CAD

What changed lately

Latest news

All Quest PharmaTech Inc. news

Quest PharmaTech Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 142 in all · newest Sep 25, 2026 · oldest 2005
Decks
1 deck · latest January 2016

Where Quest PharmaTech Inc. is listed

ListingExchangeCountryCurrency
TSXV:QPT · Home listingTSXVCanadaCAD
OTC:QPTFFOTCUnited StatesUSD
Cboe Canada:QPT · This pageCboe CanadaCanadaCAD

Valuation

Price/book 0.1× against a median of 0.3×: 2nd lowest of 9 Biotechnology companies shown. Statements: Year to Jan 31, 2026 · balance Jul 31, 2026 · price Nov 19, 2026

Enterprise value
$3.30M CAD
P/E
0.7×
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P/TSX Composite
1.90

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Quest PharmaTech Inc. · TSXV:QPTUS$2.36MUS$2.30M0.7×n/an/a0.1×n/a0.0×1.90
GRI Bio, Inc. · NASDAQ:GRIUS$2.45M−US$6.99Mn/an/an/a0.3×n/a0.0×0.89
NeuroSense Therapeutics Ltd. · NASDAQ:NRSNUS$2.43MUS$2.20Mn/an/an/an/an/an/a1.41
ValiRx PLC · LSE:VALUS$2.42MUS$1.15Mn/a28.0×n/a0.6×n/a0.0×n/a
BSF Enterprise PLC · LSE:BSFAUS$2.40MUS$2.95Mn/a42.7×n/a1.0×n/a0.3×n/a
Revelation Biosciences, Inc. · NASDAQ:REVBUS$2.39M−US$5.92Mn/an/an/a0.3×n/a0.1×1.66
Mustang Bio, Inc. · NASDAQ:MBIOUS$2.38M−US$11.89Mn/an/an/a0.4×n/a0.0×1.01
HCW Biologics Inc. · NASDAQ:HCWBUS$2.35MUS$8.23Mn/a1.2×n/a0.3×−63.4%1.0×1.19
Ernexa Therapeutics Inc. · NASDAQ:ERNAUS$2.30M−US$2.96Mn/an/an/a0.5×n/a0.1×0.86
Cynata Therapeutics Limited · ASX:CYPUS$2.26MUS$1.66Mn/a1.5×n/an/a−540.4%n/an/a
PharmaCyte Biotech, Inc. · NASDAQ:PMCBUS$2.25M−US$15.59Mn/an/an/a0.1×n/a0.0×1.97
Median of the othersUS$2.39M−US$907,86814.7×0.3×−301.9%0.0×1.19

Team and board

Officers

OfficerRole
Madi MadiyalakanChief Executive Officer, Director
Pierre VermetteChief Financial Officer
J. Mark LievonenDirector, Chairman of the Board

Board

DirectorRole
Bradley J. GlassDirector
Jeffrey ShonDirector
Madi MadiyalakanChief Executive Officer, Director

Events

QuarterResultsShare move
Q1 2024Jun 29, 2023 · After close0.0%
Q2 2023Sep 26, 2022 · After close0.0%

Open Events

Decks

DeckKindSlidesDate
AmrutBio — Investor Presentation (January 2016)Investor deck22 slidesJanuary 2016

Open Decks

Financials

Annual, in CAD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue0000000038.9K2.57K
Cost of revenue17.7K1.19K
Gross profit21.1K1.38K
Research and development242.3K329.2K542.9K336.2K170.2K212.5K11.3M6.27M5.51M2.10M
Selling, general and administrative468.9K488.1K773.0K498.0K620.3K857.8K2.37M2.78M2.31M2.22M
Operating income-711.3K-817.3K-1.32M-834.2K-790.6K-1.07M-13.6M-9.04M-7.79M-4.32M
Depreciation and amortization02.97K13.5K38.6K39.3K42.8K7.51K12.0K14.9K
EBITDA-817.3K-1.31M-820.7K-752.0K-1.03M-13.6M-9.03M-7.78M-4.30M
Interest expense20.3K22.6K20.7K21.0K13.1K7.77K13.7K4.42K00
Income before tax5.00M-1.80M-3.02M-7.33M-85.0M190.1M-13.3M-8.64M-9.11M-4.42M
Income tax00
Net income5.00M-1.80M-3.02M-7.33M-85.0M190.1M-6.18M-4.39M-5.09M-4.13M
Earnings per share, basic0.03-0.01-0.02-0.04-0.511.13-0.04-0.03-0.03

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents14.4K205.1K717.0K374.7K264.3K199.1K2.15M347.3K416.4K1.22M
Short-term investments0300.0K3.11M10.9M8.27M
Receivables221.3K32032.7K10.9K14.3K23.0K18.5K
Inventory036490.1K
Current assets32.9K225.3K835.5K621.5K288.1K281.4K2.89M4.30M12.4M10.2M
Property, plant and equipment2.97K16.5K55.0K99.2K19.7K25.5K26.8K
Total assets27.8M22.6M24.5M84.4M91.0M175.6M4.45M5.81M12.8M11.4M
Accounts payable106.4K108.6K85.1K5.86M506.7K930.2K733.5K
Current liabilities1.33M1.17M1.32M1.11M622.6K375.4K20.9M10.1M9.95M733.5K
Total liabilities1.33M1.17M1.32M1.11M622.6K389.4K20.9M10.1M9.95M733.5K
Shareholders' equity26.4M21.4M23.2M83.3M90.4M175.2M-15.3M-10.3M-7.38M11.0M
Shares outstanding169.1M169.1M169.1M169.1M168.2M168.2M167.7M167.4M167.1M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-190.7K-511.9K-342.4K-554.7K-170.8K-2.52M-6.38M-6.91M-7.33M-4.61M
Capital spending00000-38.0K-35.9K-1.63K-8.72K-8.94K
Free cash flow-190.7K-511.9K-342.4K-554.7K-170.8K-2.55M-6.38M-6.91M-7.33M-4.62M
Cash from investing-14.0K-14.0K262.0K2.78M8.26M-2.98M-24.8K
Cash from financing0684.7K679.0K250.0K299.0K5.40M-1.42M9.46M5.11M
Share buybacks9.30M9.30M
Change in cash-190.7K-511.9K342.3K110.3K65.2K-1.95M1.81M-69.1K-805.5K433.3K

Open Financials

Cap table

Built by 6ix from Quest PharmaTech Inc.’s releases

Common shares
169,129,247
Fully diluted
169,129,247

Fully diluted

LineShares
Common shares169,129,247

Share count over time

CountShares
Nov 22, 2026169,129,247

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bradley J. GlassDirector · Since at least Aug 27, 2025
Jeffrey ShonDirector · Since at least Sep 25, 2026
J. Mark LievonenDirector, Chairman of the Board · Since at least Sep 25, 2026
Madi R. MadiyalakanChief Executive Officer, Director · Since at least Sep 25, 2026
Pierre VermetteChief Financial Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Quest PharmaTech Inc.